🇺🇸 Ligand Pharmaceuticals Incorporated
Forum topic · LGND · Company page: financials, ownership and filings
Join the discussion on Ligand Pharmaceuticals Incorporated
Loading…
Insider trading in October 2026
Directors and officers of Ligand Pharmaceuticals Incorporated reported open-market trades for October 2026 (SEC Forms 4 and 5): 2 insiders sold shares worth about $1,972,206 in 11 trades.
Awards, option exercises and shares withheld for tax are not counted.
Results announced on 29 October 2026
Ligand Pharmaceuticals Incorporated announced results on 29 October 2026 (SEC Form 8-K, item 2.02).
For the quarter ended 30 September 2026: revenue of $79 million (down 32% from a year earlier) and a net loss of $28 million.
Mutual funds: 311 funds hold $3.7 billion
311 mutual funds in 2 countries hold shares of Ligand Pharmaceuticals Incorporated worth $3.7 billion, about 62.7% of the company (funds' newest reports, up to 31 July 2026).
Since their previous reports 166 funds added shares and 111 sold; on balance they bought $243 million. Share splits are not counted as trading.
Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.